Anagenics Statistics

Total Valuation

Anagenics has a market cap or net worth of AUD 3.47 million. The enterprise value is 3.63 million.

Market Cap	3.47M
Enterprise Value	3.63M

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Anagenics has 496.32 million shares outstanding. The number of shares has increased by 3.48% in one year.

Current Share Class	n/a
Shares Outstanding	496.32M
Shares Change (YoY)	+3.48%
Shares Change (QoQ)	-36.50%
Owned by Insiders (%)	18.11%
Owned by Institutions (%)	30.63%
Float	169.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.48
PB Ratio	1.54
P/TBV Ratio	11.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.60
EV / Sales	0.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.77

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.28.

Current Ratio	1.08
Quick Ratio	0.47
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	-0.31
Interest Coverage	-62.92

Financial Efficiency

Return on equity (ROE) is -135.49% and return on invested capital (ROIC) is -39.11%.

Return on Equity (ROE)	-135.49%
Return on Assets (ROA)	-27.30%
Return on Invested Capital (ROIC)	-39.11%
Return on Capital Employed (ROCE)	-140.34%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.93
Inventory Turnover	2.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.00% in the last 52 weeks. The beta is -0.08, so Anagenics's price volatility has been lower than the market average.

Beta (5Y)	-0.08
52-Week Price Change	-60.00%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	67.04
Average Volume (20 Days)	10,865

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Anagenics had revenue of AUD 7.26 million and -6.01 million in losses. Loss per share was -0.02.

Revenue	7.26M
Gross Profit	2.81M
Operating Income	-3.41M
Pretax Income	-6.38M
Net Income	-6.01M
EBITDA	-3.00M
EBIT	-3.41M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 471,133 in cash and 628,726 in debt, giving a net cash position of -157,593 or -0.00 per share.

Cash & Cash Equivalents	471,133
Total Debt	628,726
Net Cash	-157,593
Net Cash Per Share	-0.00
Equity (Book Value)	2.25M
Book Value Per Share	0.00
Working Capital	158,117

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.04 million and capital expenditures -14,618, giving a free cash flow of -2.06 million.

Operating Cash Flow	-2.04M
Capital Expenditures	-14,618
Free Cash Flow	-2.06M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 38.68%, with operating and profit margins of -47.07% and -82.77%.

Gross Margin	38.68%
Operating Margin	-47.07%
Pretax Margin	-87.89%
Profit Margin	-82.77%
EBITDA Margin	-41.30%
EBIT Margin	-47.07%
FCF Margin	n/a

Dividends & Yields

Anagenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.48%
Shareholder Yield	-3.48%
Earnings Yield	-172.87%
FCF Yield	-59.21%

Stock Splits

The last stock split was on November 27, 2017. It was a reverse split with a ratio of 0.05.

Last Split Date	Nov 27, 2017
Split Type	Reverse
Split Ratio	0.05

Scores

Anagenics has an Altman Z-Score of -20.56. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-20.56
Piotroski F-Score	n/a